Chief law officer Josh Hawley revealed that Missouri will get over $3.1 million as part of a $465 million settlement versus Mylan Inc. This settlement solves accusations that Mylan purposefully underpaid refunds owed to Missouri’s Medicaid program for the sales of EpiPen and EpiPen Jr.
The case declared that from July 29, 2010 to March 31, 2017, Mylan sent incorrect declarations to the Centers for Medicare and Medicaid Services (CMS) that improperly categorized EpiPen as a “non-innovator numerous source” drug, instead of a “single source” or “innovator several source” drug, as those terms are specified in the Rebate Statute and Rebate Agreement. Mylan also did not report a Best Price to CMS for EpiPen, which it was needed to do for all “single source” and “innovator several source” drugs. As an outcome, Mylan sent or triggered to be sent incorrect declarations to CMS connecting to EpiPen for Medicaid refund functions, and underpaid its EpiPen refunds to State Medicaid programs, consisting of Missouri.
“There is no place for Medicaid Fraud in Missouri,” Hawley stated. “We will not endure the abuse of taxpayer money. I am grateful to the firms that dealt with this case and I am delighted that this money will be returned.”
Attorney general of the United States Hawley motivates people to report believed Medicaid scams to his workplace. State law offers that a whistleblower might be entitled to 10 percent of any Medicaid scams money recuperated in a civil fit as an outcome of their idea. Missourians can report believed Medicaid supplier scams and abuse through the Attorney General’s Medicaid Fraud Hotline at 800-286-3932 or online at http://ago.mo.gov/divisions/medicaid-provider-fraud.